LOGO.jpg
Costamare Inc. Reports Results for the Fourth Quarter and Year Ended December 31, 2023
February 07, 2024 05:57 ET | Costamare Inc
MONACO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the fourth quarter (“Q4 2023”) and year ended...
Las Vegas-Clark County Library District Executive Director Kelvin Watson
Las Vegas-Clark County Library District Executive Director Kelvin Watson Receives City of Las Vegas African American Trailblazer Service Award
January 26, 2024 13:07 ET | Las Vegas-Clark County Library District
Las Vegas, NV, United States, Jan. 26, 2024 (GLOBE NEWSWIRE) -- In honor of Black History Month, the city of Las Vegas presented Las Vegas-Clark County Library District Executive Director Kelvin...
Matthew Valdez Headshot
Learn & Work Ecosystem Library Announces New Librarian and Updated Features
December 05, 2023 12:15 ET | Learn & Work Ecosystem Library
The Learn & Work Ecosystem Library hired Matthew Valdez as its first Librarian and has updated digital features for its 1-year anniversary.
LML Logo Crop (1).png
Love My Library Disrupts the Traditional Book Fair Model and Challenges Scholastic's Dominance in the Market
November 28, 2023 07:02 ET | Love My Library
Mansfield, TX, Nov. 28, 2023 (GLOBE NEWSWIRE) -- In a groundbreaking departure from the status quo, Love My Library ("LML"), home to the reimagined book fair, has ignited a movement, challenging...
lianbio_logo_V.png
联拓生物发布2023年第三季度财务业绩数据及公司近期经营动态
November 13, 2023 16:05 ET | LianBio
联拓生物与百时美施贵宝就mavacamten在中国和其它亚洲市场达成协议EXPLORER-CN的III期研究结果在欧洲心脏病学会年会Late-Breaking专场进行口头公布,并同步发表于《JAMA Cardiology》TP-03治疗中国蠕形螨睑缘炎患者的III期临床试验的顶线结果公布截至2023年9月30日,公司拥有现金、现金等价物和有价证券合计2.522亿美元公司正在对业务开展战略评估 ...
lianbio_logo_V.png
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023 16:05 ET | LianBio
Entered into agreement with Bristol Myers Squibb for mavacamten in China and other Asian marketsPhase 3 data from EXPLORER-CN trial of mavacamten presented in an oral late-breaking science session at...
NMM Logo.jpg
Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2023
November 02, 2023 08:04 ET | Navios Maritime Partners L.P.
Revenue: $323.2 million for Q3 2023$979.6 million for 9M 2023 Net Income: $  89.8 million for Q3 2023$301.3 million for 9M 2023 Earnings per common unit: $2.92 for Q3 2023$9.78 for 9M 2023 Net...
LOGO.jpg
Costamare Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023
November 01, 2023 06:53 ET | Costamare Inc
MONACO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the third quarter (“Q3 2023”) and nine-months...
lianbio_logo_V.png
LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
October 30, 2023 16:05 ET | LianBio
SHANGHAI, China and PRINCETON, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major...
lianbio_logo_V.png
联拓生物公布TP-03在中国蠕形螨睑缘炎患者中开展的 III期临床研究LIBRA的最新结果
October 30, 2023 16:05 ET | LianBio
上海和新泽西州普林斯顿, Oct. 31, 2023 (GLOBE NEWSWIRE) -- 联拓生物 (纳斯达克:LIAN),一家致力于为中国和其他主要亚洲市场的患者带来创新药物的生物技术公司,于今日公布了评估TP-03治疗中国蠕形螨睑缘炎患者的III期临床研究LIBRA的顶线数据结果。 ...